☆ 4.4 Article

Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice

JOURNAL OF CLINICAL LIPIDOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease

Elias J. Dayoub et al.

Summary: Although PCSK9 inhibitors represent a promising class of lipid-lowering therapy, few ASCVD patients initiated this treatment from 2015 through mid-2019, despite increasing trial evidence and guideline recommendations. The magnitude of price reductions during this period may not yet be sufficient to influence management strategies aimed at limiting the use of PCSK9 inhibitors.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US

Christopher P. Cannon et al.

Summary: This study tracked LDL-C treatment patterns in US patients with atherosclerotic cardiovascular disease over 2 years and found that only 17.1% of patients had lipid-lowering therapy intensification after 2 years, with most patients still having LDL-C levels greater than 70 mg/dL. Efforts are needed to achieve optimal LDL-C management in patients with ASCVD.

JAMA CARDIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

Kausik K. Ray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial: Insight From the Veterans Affairs Healthcare System

Xiaoming Jia et al.

CIRCULATION (2019)

添加到收藏夹

Article Medicine, General & Internal

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

Kausik K. Ray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance

Ulrich Laufs et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary

Scott M. Grundy et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Deepak L. Bhatt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

G. G. Schwartz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study

Dennis T. Ko et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis

Nathan D. Wong et al.

JOURNAL OF CLINICAL LIPIDOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Marc S. Sabatine et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Medicine, General & Internal

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Christopher P. Cannon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.